Julia Quidde

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

Susanna Hegewisch‐Becker, Ullrich Graeven, Christian Lerchenmüller et al. · The Lancet Oncology · 2015 · 246 citations

Maintenance Strategies, Aio 0207, Medicine +7

A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells

G.E. Hvichia, Zahida Parveen, Cosima Wagner et al. · International Journal of Cancer · 2016 · 186 citations · Full text

Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®

Tobias M. Gorges, Alexander Stein, Julia Quidde et al. · PLoS ONE · 2016 · 73 citations · Full text

Circulating Tumor Cells, Immunology, Pathology +20

T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker

Nuray Akyüz, Anna Brandt, Alexander Stein et al. · International Journal of Cancer · 2016 · 49 citations · Full text

T-regulatory Cell, Immunology, T-cell Diversification +22

Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial

Julia Quidde, Susanna Hegewisch‐Becker, Ullrich Graeven et al. · Annals of Oncology · 2016 · 28 citations · Full text

Life Assessment, Surgical Oncology, Gastrointestinal Oncology +9